Literature DB >> 31961717

Fibrotic liver has prompt recovery after ischemia-reperfusion injury.

Takanori Konishi1, Rebecca M Schuster1, Holly S Goetzman1, Charles C Caldwell1, Alex B Lentsch1.   

Abstract

Hepatic ischemia-reperfusion (I/R) is a major complication of liver resection, trauma, and liver transplantation; however, liver repair after I/R in diseased liver has not been studied. The present study sought to determine the manner in which the fibrotic liver repairs itself after I/R. Liver fibrosis was established in mice by CCl4 administration for 6 wk, and then liver I/R was performed to investigate liver injury and subsequent liver repair in fibrotic and control livers. After I/R, fibrotic liver had more injury compared with nonfibrotic, control liver; however, fibrotic liver showed rapid resolution of liver necrosis and reconstruction of liver parenchyma. Marked accumulation of hepatic stellate cells and macrophages were observed specifically in the fibrotic septa in early reparative phase. Fibrotic liver had higher numbers of hepatic stellate cells, macrophages, and hepatic progenitor cells during liver recovery after I/R than did control liver, but hepatocyte proliferation was unchanged. Fibrotic liver also had significantly greater number of phagocytic macrophages than control liver. Clodronate liposome injection into fibrotic mice after I/R caused decreased macrophage accumulation and delay of liver recovery. Conversely, CSF1-Fc injection into normal mice after I/R resulted in increased macrophage accumulation and concomitant decrease in necrotic tissue during liver recovery. In conclusion, fibrotic liver clears necrotic areas and restores normal parenchyma faster than normal liver after I/R. This beneficial response appears to be directly related to the increased numbers of nonparenchymal cells, particularly phagocytic macrophages, in the fibrotic liver.NEW & NOTEWORTHY This study is the first to reveal how diseased liver recovers after ischemia-reperfusion (I/R) injury. Although it was not completely unexpected that fibrotic liver had increased hepatic injury after I/R, a novel finding was that fibrotic liver had accelerated recovery and repair compared with normal liver. Enhanced repair after I/R in fibrotic liver was associated with increased expansion of phagocytic macrophages, hepatic stellate cells, and progenitor cells.

Entities:  

Keywords:  hepatic progenitor cells; liver fibrosis; liver repair; macrophages; stellate cells

Mesh:

Year:  2020        PMID: 31961717      PMCID: PMC7099490          DOI: 10.1152/ajpgi.00137.2019

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  49 in total

1.  Effects of ischemia and reperfusion on oxidative stress in hepatic cirrhosis induced by carbon tetrachloride in rats.

Authors:  E L Rhoden; L Pereira-Lima; A N Kalil; M L Lucas; M Mauri; E Menti; C R Rhoden; J Pereira-Lima; C G Zettler; A Belló-Klein
Journal:  Kobe J Med Sci       Date:  2000-08

Review 2.  Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells.

Authors:  Nelson Fausto
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

3.  Hepatocyte buds derived from progenitor cells repopulate regions of parenchymal extinction in human cirrhosis.

Authors:  Ashley E Stueck; Ian R Wanless
Journal:  Hepatology       Date:  2015-03-18       Impact factor: 17.425

Review 4.  Macrophages in Tissue Repair, Regeneration, and Fibrosis.

Authors:  Thomas A Wynn; Kevin M Vannella
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

Review 5.  Understanding Liver Regeneration: From Mechanisms to Regenerative Medicine.

Authors:  Hélène Gilgenkrantz; Alexandra Collin de l'Hortet
Journal:  Am J Pathol       Date:  2018-04-16       Impact factor: 4.307

6.  Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-01-11       Impact factor: 4.052

7.  Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.

Authors:  Prakash Ramachandran; Antonella Pellicoro; Madeleine A Vernon; Luke Boulter; Rebecca L Aucott; Aysha Ali; Stephen N Hartland; Victoria K Snowdon; Andrea Cappon; Timothy T Gordon-Walker; Mike J Williams; Donald R Dunbar; Jonathan R Manning; Nico van Rooijen; Jonathan A Fallowfield; Stuart J Forbes; John P Iredale
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-24       Impact factor: 11.205

Review 8.  Hepatic Ischemia/Reperfusion: Mechanisms of Tissue Injury, Repair, and Regeneration.

Authors:  Takanori Konishi; Alex B Lentsch
Journal:  Gene Expr       Date:  2017-09-11

Review 9.  Differentiation of progenitors in the liver: a matter of local choice.

Authors:  Luke Boulter; Wei-Yu Lu; Stuart J Forbes
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

10.  Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group.

Authors: 
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

View more
  6 in total

1.  Liver Ischemia and Reperfusion Induce Periportal Expression of Necroptosis Executor pMLKL Which Is Associated With Early Allograft Dysfunction After Transplantation.

Authors:  Shaojun Shi; Eliano Bonaccorsi-Riani; Ivo Schurink; Thierry van den Bosch; Michael Doukas; Karishma A Lila; Henk P Roest; Daela Xhema; Pierre Gianello; Jeroen de Jonge; Monique M A Verstegen; Luc J W van der Laan
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

2.  Distinct Neutrophil Populations in the Spleen During PICS.

Authors:  Satarupa Sengupta; Charles C Caldwell; Vanessa Nomellini
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

3.  Therapeutic potential of macrophage colony-stimulating factor in chronic liver disease.

Authors:  Sahar Keshvari; Berit Genz; Ngari Teakle; Melanie Caruso; Michelle F Cestari; Omkar L Patkar; Brian W C Tse; Kamil A Sokolowski; Hilmar Ebersbach; Julia Jascur; Kelli P A MacDonald; Gregory Miller; Grant A Ramm; Allison R Pettit; Andrew D Clouston; Elizabeth E Powell; David A Hume; Katharine M Irvine
Journal:  Dis Model Mech       Date:  2022-04-19       Impact factor: 5.732

Review 4.  Role of hepatic stellate cells in liver ischemia-reperfusion injury.

Authors:  Yuming Peng; Qiang Yin; Miaoxian Yuan; Lijian Chen; Xinyi Shen; Weixin Xie; Jinqiao Liu
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

5.  PIAS1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice through a Mechanism Involving NFATc1 SUMOylation.

Authors:  Jing Luo; Jiequn Li; Ting Li; Zhongqiang Zhang; Guangshun Chen; Qiang Li; Haizhi Qi; Zhongzhou Si
Journal:  Dis Markers       Date:  2022-08-31       Impact factor: 3.464

6.  Donor Hepatic Occult Collagen Deposition Predisposes to Peritransplant Stress and Impacts Human Liver Transplantation.

Authors:  Hirofumi Hirao; Takahiro Ito; Jerzy W Kupiec-Weglinski; Fady M Kaldas; Kentaro Kadono; Hidenobu Kojima; Bita V Naini; Kojiro Nakamura; Shoichi Kageyama; Ronald W Busuttil
Journal:  Hepatology       Date:  2021-08-30       Impact factor: 17.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.